K-Cab Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

A total of 5 clinical studies were conducted with erosive gastroesophageal reflux disease and non-erosive gastroesophageal reflux disease and gastric ulcer patients. 360 patients were treated with tegoprazan 50 mg. Adverse events and adverse drug reactions (marked with *) reported during the clinical trials are as following: Adverse events reported in at least 1% of subjects: See Table 1.

Click on icon to see table/diagram/image

Adverse events reported in at less 1% of subjects: See Table 2.

Click on icon to see table/diagram/image

A clinical study was conducted in patients with peptic ulcer and/or chronic atrophic gastritis who were positive for H. pylori. 172 patients were treated with tegoprazan 50 mg, in combination with amoxicillin 1 g and clarithromycin 500 mg. Adverse events and adverse drug reactions (marked with *) reported during the clinical trial is as following: Adverse events reported in at least 1% of subjects: See Table 3.

Click on icon to see table/diagram/image

Adverse events reported in less than 1% of subjects: See Table 4.

Click on icon to see table/diagram/image

View ADR Reporting Link

Manufacturer:

HK inno.

Distributor:

Pacific Healthcare

Marketer:

Pacific Healthcare